Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Immunogenicity and clinical efficacy of influenza vaccination in pregnancy FRONTIERS IN IMMUNOLOGY Kay, A. W., Blish, C. A. 2015; 6: 1-9

Abstract

Pregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high-priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogeneic fetus may alter the immunogenicity of influenza vaccines. A large number of studies have evaluated the safety of the influenza vaccine. Here, we will review available studies on the immunogenicity and efficacy of the influenza vaccine during pregnancy, focusing on both humoral and cellular immunity.

View details for DOI 10.3389/fimmu.2015.00289

View details for Web of Science ID 000357155700001

View details for PubMedCentralID PMC4455389